The invention relates to a composition comprising taurolidine and/or the hydrolysis products thereof and also a biodegradable (co)polymer or inorganic matrix for use as an implant for treating local infections of the skeleton and soft tissue. A lozenge and a spray solution or gargling solution likewise comprises taurolidine and/or the hydrolysis products thereof and is used in the treatment of throat inflammations, sore throats with difficulty in swallowing, inflammations of the mouth and throat area and laryngitis. A method for producing taurolidine is also disclosed.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K 31/549 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
C07D 209/48 - Iso-indolesHydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
C07D 237/32 - Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
C07D 285/24 - 1,2,4-ThiadiazinesHydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
C07D 417/06 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
A61K 9/00 - Medicinal preparations characterised by special physical form
2.
INHALATION DEVICE AND METHOD FOR INHALING AN ACTIVE INGREDIENT FROM A CAPSULE
The invention relates to an inhalation device for inhaling at least one active ingredient contained in a capsule, comprising: - a swirl chamber (15) for accommodating a capsule and for swirling the capsule content, - at least one air introduction channel (13), and at least one air discharge channel (14), wherein the air introduction channel (13) and the swirl chamber (15) and the air discharge channel (14) are in fluid connection and wherein the air introduction channel (13) and the air discharge channel (14) extend at least partially in opposite directions. The invention further relates to methods for inhaling an active ingredient contained in a capsule.
patents